Conversely, silencing the constitutively active PTPN11E76K expression caused regression of melanomas by apoptosis and senescence in a preclinical model [255]; more importantly, the SHP2 inhibitor SHP099 promoted regression of NRASQ61K -mutant melanomas in mice models [255]. The gene discussed is PTPN11; the disease is melanoma.